For example, tumor-associated Dendritic Cells (DCs) display increased levels of IDO and β-catenin target genes, decrease T cell activation in vitro and can induce the differentiation and activation of T regulatory cells (Tregs) in a β-catenin pathway-dependent fashion (Figure 1) [71]. This evidence concerns the gene IDO1 and neoplasm.